Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
about
Glucagon secretion and signaling in the development of diabetesHypoglycemia in Patients with Diabetes and Renal DiseaseRisk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusStructure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptorsOptimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiencyAssociation of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetesModels of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.Pancreatic network control of glucagon secretion and counterregulation.System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated ratsCapacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans.Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistanceCurrent understanding of feline diabetes: part 2, treatment.Insulin.Intensified conventional insulin treatment and neuropsychological impairment.Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.Diabetes in puberty.Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action.The management of diabetic emergencies.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.cAMP signalling in insulin and glucagon secretion.Unperturbed islet α-cell function examined in mouse pancreas tissue slices.Glucose counterregulation: prevention and correction of hypoglycemia in humans.Effect of age and endurance training on the capacity for epinephrine-stimulated gluconeogenesis in rat hepatocytes.In situ electrophysiological examination of pancreatic α cells in the streptozotocin-induced diabetes model, revealing the cellular basis of glucagon hypersecretion.Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.Hypoglycemic effect of aqueous extract of Ammi visnaga in normal and streptozotocin-induced diabetic rats.GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.The Cells of the Islets of Langerhans.
P2860
Q21129250-3191C43D-05FA-4BE9-81AE-82273B0CE06BQ26799515-0181F069-5155-400E-97E0-58CCFF25B1B1Q28072980-03C6A8C0-8936-4407-B6C5-F07B327791B7Q28203273-90921B2D-F974-475F-AC75-E84EF4E1B350Q30424699-EBF8A612-9184-49B8-921B-4B608DBB5ED0Q30427914-683E73E0-9577-4459-BDBF-A8BD4AB4BA23Q30429992-F61E329E-EB7D-4B99-9048-A80280695A34Q30432736-7F148773-D7A8-41AE-A26B-21904599E610Q30437499-288F52F3-53FE-44F5-8216-05BB3CBA2BBBQ30438739-05E2BE98-BBA0-447C-A1F9-0D5F0C0FE263Q33198296-730A304E-0DF7-4773-9D80-48E4B5687FA9Q33588931-9B5E0AEA-5EA4-43D8-A887-7E1180469A14Q34444640-52F384C6-18F4-4F14-89DF-06A2E726E828Q35168333-B440A6DD-FCC5-4605-A6F0-D7A4F60BB2C4Q35181629-51197AD2-F5E1-4C49-BB08-17BF568CD3B1Q35612681-67AE78B2-31DD-47DB-9103-E042F868C0AAQ35817929-A61CFF63-B699-40AB-A4C0-91D61FB2431CQ36181802-1DF3AA4F-4096-47D5-81B5-9F1924272F99Q36325757-B230EA7D-8B89-4B4D-8BCA-3386B42B4118Q38225195-DF733961-C3E0-4B09-AFF1-119953E76B80Q38297682-BA7455B2-42A7-4581-84E8-11D9A9AEC8C3Q38798115-435EB1A0-2BAD-4C1F-970B-781BCE4C1B69Q39280145-A6306B96-BC89-4A4F-9A80-669F5F6516E6Q39816977-0A17D11F-2458-4E25-AA94-A38C4CF85B54Q40883259-DEE9B91A-DA33-44F0-98AF-17369770FA17Q42444399-9FBF4090-9FB4-47A0-A6AF-F48E4E79AB3CQ42965724-421185AF-D825-4D57-B03B-B3A58F31E747Q43510788-29AFAB02-115D-405F-AE67-1B1625213EDCQ44995301-216F0241-A9EB-432F-99A3-F84C66A700BEQ52579817-9243048B-F0A4-4E80-8D41-DAFAB5005A2EQ52657734-3C8E5D7E-1CE7-44B8-BAA0-A5231193E506
P2860
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@ast
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@en
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@nl
type
label
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@ast
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@en
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@nl
prefLabel
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@ast
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@en
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@nl
P3181
P356
P1433
P1476
Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus
@en
P2093
J E Gerich
P304
P3181
P356
10.2337/DIAB.37.12.1608
P407
P577
1988-12-01T00:00:00Z